APAP for Obstructive Sleep Apnea in Mental Illness

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, San Diego

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial is testing a treatment called Positive Airway Pressure (PAP) for adults with serious mental illnesses like schizophrenia and bipolar disorder who also have sleep apnea. PAP treatment uses a machine to help keep the airways open during sleep by providing a steady stream of air through a mask. The study aims to see if this treatment can improve cognitive function and overall health in these patients over several months. Positive Airway Pressure (PAP) is the standard and most effective treatment for obstructive sleep apnea (OSA).

Eligibility Criteria

This trial is for adults aged 40-70 with serious mental illnesses like schizophrenia or bipolar disorder, who may also have or be at risk for obstructive sleep apnea. Participants should not have other major psychiatric conditions and must not be under conservatorship.

Inclusion Criteria

I am at risk for or have been diagnosed with obstructive sleep apnea.

I have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder.

You have never had a serious mental illness in your life.

Treatment Details

Interventions

• Automatic Positive Airway Pressure (APAP) (Positive Airway Pressure Device)

Trial Overview The study is testing the use of Automatic Positive Airway Pressure (APAP) machines to treat obstructive sleep apnea in individuals with serious mental illnesses, assessing how it might improve their cognitive function.

Participant Groups

Group I: Automatic Positive Airway Pressure (APAP) device Experimental Treatment 1 Intervention

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials

1,215

Recruited

1,593,000+